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Structural characterization of enzyme-ligand complexes of GDP-
Mannose hehydrogenase from P. aerguinosa  
 
The enzyme GDP-mannose dehydrogenase (GMD) from Pseudomonas aeruginosa catalyzes the 
committed step in the synthesis of the exopolysaccharide alginate.  Alginate is a major component of 
P. aeruginosa biofilms that enable the organism to survive under harsh environmental conditions, and 
also protect it from antibiotic therapy.  GMD catalyzes the NAD+ dependent, 4-electron oxidation of 
GDP-mannose to GDP-mannuronic acid, which acts as the donor to the homopolymeric alginate 
precursor.  Previously our laboratory has determined the crystal structure of GMD at 1.55 ≈ in ternary 
complex with its cofactor NAD(H) and product GDP-mannuronic acid.  The structure provided valuable 
three-dimensional information on the enzyme's active site and contacts between the protein and its 
cofactor and product.  However, important questions regarding GMD remain, including the structural 
basis for the enzyme's ability to catalyze two different oxidations in a single active site, and the 
identification of residues involved in the formation of the proposed enzyme-intermediate complexes.  
To address these questions, we are characterizing several GMD-ligand complexes by X-ray 
crystallography.  Site-directed mutants based on the crystal structure have been produced and 
characterized kinetically.  These mutant GMD proteins have been used in co-crystallization 
experiments to capture "snapshots" of the individual steps of the reaction.  Structural characterization 
of these complexes is underway and will illuminate the multi-step reaction mechanism of GMD.   They 
will also serve as templates for efforts at structure-based inhibitor design that could help fight P. 
aeruginosa infections. 
 
